Stay updated with breaking news from Jersey Based Catalent. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
It was a busy year for the Indiana life sciences community, with a flurry of billion-dollar deals, major announcements, and a few setbacks. Here we present the top 10 stories of 2023—the good, the bad and the ugly—about an industry that is often hailed as a key driver of Indiana’s economy.
/cloudfront-us-east-2.images.arcpublishing.com/reuters/RAX34RTZZ5PWXMSULCJQ2XH6JE.jpg)
2 minute read A vial labelled with the AstraZeneca coronavirus disease (COVID-19) vaccine is seen in this illustration picture taken March 19, 2021. REUTERS/Dado Ruvic/Illustration/File Photo AstraZeneca Plc (AZN.L) is in talks with the U.S. government to shift production of its COVID-19 vaccine from a troubled Baltimore plant to a factory owned by Catalent Inc (CTLT.N), the New York Times reported, citing people familiar with the matter. The British drugmaker has been on the lookout for an alternative production site since the U.S. government stopped it from using Emergent BioSolutions Inc's...